SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock
42.18 EUR
+0.41 (+0.98%)
Taking everything into account, SHL scores 5 out of 10 in our fundamental rating. SHL was compared to 63 industry peers in the Health Care Equipment & Supplies industry. SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. SHL has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
In the past year SHL had a positive cash flow from operations.
SHL had positive earnings in each of the past 5 years.
Each year in the past 5 years SHL had a positive operating cash flow.
1.2 Ratios
SHL has a Return On Assets of 4.83%. This is in the better half of the industry: SHL outperforms 65.08% of its industry peers.
SHL has a Return On Equity of 11.88%. This is in the better half of the industry: SHL outperforms 71.43% of its industry peers.
SHL has a better Return On Invested Capital (7.65%) than 65.08% of its industry peers.
SHL had an Average Return On Invested Capital over the past 3 years of 6.28%. This is below the industry average of 9.33%.
The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROIC | 7.65% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
SHL has a better Profit Margin (9.17%) than 66.67% of its industry peers.
SHL's Profit Margin has been stable in the last couple of years.
SHL has a better Operating Margin (13.53%) than 63.49% of its industry peers.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
Looking at the Gross Margin, with a value of 38.63%, SHL is doing worse than 77.78% of the companies in the same industry.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SHL is creating some value.
Compared to 1 year ago, SHL has more shares outstanding
Compared to 5 years ago, SHL has more shares outstanding
SHL has a better debt/assets ratio than last year.
2.2 Solvency
SHL has an Altman-Z score of 1.98. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.98, SHL is in line with its industry, outperforming 46.03% of the companies in the same industry.
The Debt to FCF ratio of SHL is 5.45, which is a neutral value as it means it would take SHL, 5.45 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.45, SHL is in line with its industry, outperforming 55.56% of the companies in the same industry.
A Debt/Equity ratio of 0.63 indicates that SHL is somewhat dependend on debt financing.
SHL has a worse Debt to Equity ratio (0.63) than 69.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 1.98 |
ROIC/WACC1.21
WACC6.35%
2.3 Liquidity
A Current Ratio of 1.11 indicates that SHL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.11, SHL is doing worse than 71.43% of the companies in the same industry.
SHL has a Quick Ratio of 1.11. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SHL (0.79) is worse than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.17%.
SHL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.29% yearly.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 4.53% in the last year.
The Revenue has been growing by 10.08% on average over the past years. This is quite good.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
3.2 Future
The Earnings Per Share is expected to grow by 13.66% on average over the next years. This is quite good.
SHL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.04% yearly.
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
EPS Next 5Y13.66%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y6.41%
Revenue Next 5Y5.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 17.65 indicates a rather expensive valuation of SHL.
SHL's Price/Earnings ratio is rather cheap when compared to the industry. SHL is cheaper than 85.71% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.65. SHL is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.53, SHL is valued correctly.
SHL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SHL is cheaper than 69.84% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SHL to the average of the S&P500 Index (34.45), we can say SHL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.65 | ||
| Fwd PE | 16.53 |
4.2 Price Multiples
66.67% of the companies in the same industry are more expensive than SHL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaper than 84.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.53 | ||
| EV/EBITDA | 13.25 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHL does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)2.6
PEG (5Y)1.56
EPS Next 2Y9.66%
EPS Next 3Y11.45%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.30%, SHL has a reasonable but not impressive dividend return.
SHL's Dividend Yield is rather good when compared to the industry average which is at 2.22. SHL pays more dividend than 80.95% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
5.2 History
The dividend of SHL has a limited annual growth rate of 4.33%.
Dividend Growth(5Y)4.33%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.72% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.72%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
FRA:SHL (11/24/2025, 7:00:00 PM)
42.18
+0.41 (+0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap47.58B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts82.96
Price Target57.22 (35.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.3% |
Yearly Dividend0.95
Dividend Growth(5Y)4.33%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-7.54%
PT rev (3m)-7.54%
EPS NQ rev (1m)-9.25%
EPS NQ rev (3m)-9.25%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.51%
Revenue NQ rev (1m)1.21%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.65 | ||
| Fwd PE | 16.53 | ||
| P/S | 2.04 | ||
| P/FCF | 17.53 | ||
| P/OCF | 13.47 | ||
| P/B | 2.64 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.25 |
EPS(TTM)2.39
EY5.67%
EPS(NY)2.55
Fwd EY6.05%
FCF(TTM)2.41
FCFY5.7%
OCF(TTM)3.13
OCFY7.42%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)2.6
PEG (5Y)1.56
Graham Number29.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROCE | 9.97% | ||
| ROIC | 7.65% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 43.54% | ||
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% | ||
| FCFM | 11.61% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.78%
ROICexc(5y)6.63%
ROICexgc(3y)34.62%
ROICexgc(5y)34.83%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y13.77%
ROICexgc growth 5Y12.12%
ROICexc growth 3Y9.41%
ROICexc growth 5Y-1.08%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 63.12% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 7.04 | ||
| Cash Conversion | 79.23% | ||
| Profit Quality | 126.59% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 1.98 |
F-Score8
WACC6.35%
ROIC/WACC1.21
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y6.78%
EPS Next 2Y9.66%
EPS Next 3Y11.45%
EPS Next 5Y13.66%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year4.22%
Revenue Next 2Y5.11%
Revenue Next 3Y6.41%
Revenue Next 5Y5.04%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year40.06%
EBIT Next 3Y18.71%
EBIT Next 5Y13.72%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 6 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 17.65 and the Price/Book (PB) ratio is 2.64.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.